Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Dermatology (Basel, Switzerland)|June 6, 2013
Management of small and intermediate congenital nevi: a nationwide survey in ItalyIgnazio Stanganelli, Paolo Ascierto, Riccardo Bono, et al.Dermatology (Basel, Switzerland)|June 6, 2013
Impact of mole mapping in the Italian health systemIgnazio Stanganelli, Paolo Ascierto, Riccardo Bono, et al.Minerva Dental and Oral Science|February 10, 2023
Oral immune-related adverse events caused by immune checkpoint inhibitors: a retrospective studyMichele DI Cosola, Francesca Spirito, Piermichele Saracino, et al.Dermatology (Basel, Switzerland)|June 6, 2013
Surgical management of suspicious melanocytic lesions in ItalyVincenzo De Giorgi, Paolo Ascierto, Riccardo Bono, et al.Cancer|February 18, 2010
Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trialGiuseppe Di Lorenzo, Sisto Perdonà, Rocco Damiano, et al.Journal of Translational Medicine|February 14, 2008
The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forwardMichele Maio, Hugues Jm Nicolay, Paolo Ascierto, et al.Dermatology (Basel, Switzerland)|June 6, 2013
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanomaVanna Chiarion-Sileni, Michele Guida, Antonella Romanini, et al.Journal of Translational Medicine|December 22, 2020
Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detectionLeonardo Miscio, Antonio Olivieri, Francesco Labonia, et al.Journal of Experimental & Clinical Cancer Research : CR|January 16, 2014
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programmeMaresa Altomonte, Anna Di Giacomo, Paola Queirolo, et al.Journal of Experimental & Clinical Cancer Research : CR|November 3, 2012
The cost of unresectable stage III or stage IV melanoma in ItalyMichele Maio, Paolo Ascierto, Alessandro Testori, et al.Pageof 3